GSA Capital Partners LLP Has $215,000 Holdings in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE)

GSA Capital Partners LLP decreased its holdings in shares of iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) by 28.7% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,046 shares of the company’s stock after selling 1,225 shares during the quarter. GSA Capital Partners LLP’s holdings in iShares U.S. Pharmaceuticals ETF were worth $215,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also modified their holdings of IHE. Cultivar Capital Inc. bought a new position in iShares U.S. Pharmaceuticals ETF in the second quarter valued at approximately $25,000. US Bancorp DE lifted its stake in shares of iShares U.S. Pharmaceuticals ETF by 137.0% during the 3rd quarter. US Bancorp DE now owns 384 shares of the company’s stock worth $27,000 after buying an additional 222 shares during the last quarter. Rothschild Investment LLC bought a new stake in shares of iShares U.S. Pharmaceuticals ETF during the second quarter worth approximately $26,000. Mather Group LLC. acquired a new position in iShares U.S. Pharmaceuticals ETF in the 2nd quarter valued at $29,000. Finally, Assetmark Inc. boosted its holdings in iShares U.S. Pharmaceuticals ETF by 100.0% in the 3rd quarter. Assetmark Inc. now owns 432 shares of the company’s stock valued at $31,000 after purchasing an additional 216 shares during the period.

iShares U.S. Pharmaceuticals ETF Price Performance

Shares of NYSEARCA:IHE opened at $68.39 on Monday. The company has a market capitalization of $690.74 million, a P/E ratio of 6.49 and a beta of 0.58. The business’s 50 day simple moving average is $70.04 and its 200 day simple moving average is $68.77. iShares U.S. Pharmaceuticals ETF has a 1 year low of $57.96 and a 1 year high of $72.94.

iShares U.S. Pharmaceuticals ETF Company Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.